Finland· FI-REL-REL10651
Noxacin
A norfloxacin product containing norfloxacin, registered in Finland by ratiopharm Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Norfloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC J01MA06 (norfloxacin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Norfloxacin · ATC J01MA06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of norfloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.65 in Italy to $3.00 in Switzerland — a ×4.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Norfloxacin · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.00
- IT Italy$0.65
The record
At a glance
Fimea (Finland)- Active substance
- Norfloxacin
- Manufacturer
- ratiopharm Oy
- Country
- Finland (FI)
- ATC code
- J01MA06
- ATC class
- Norfloxacin
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
467 interactions on record for norfloxacin.
Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norfloxacin · interactions on record
467 records
- 86 severe
- 219 moderate
- 51 minor
- 42 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PrednisoloneA07EA01severe
69 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Norfloxacin in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGYRABLOCKMedochemie Ltd., Limassol
- PolandNolicinMedezin Sp. z o.o.
- SpainNORFLOXACINO CINFA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- FranceNORFLOXACINE ARROW 400 mg, comprimé pelliculéARROW GENERIQUES
- NetherlandsNorfloxacine CF 400 mg, omhulde tablettenCentrafarm B.V.
- ItalyNORFLOXACINA SANDOZSANDOZ S.P.A.
- BelgiumNorfloxacine EG 400 mgEG
- United KingdomNorfloxacin 400mg tabletsSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Floxacin Stada, Norfloxacin Sandoz
- Bulgaria · Нолицин
- Cyprus · Gyrablock, Trizolin
- Czechia · Gyrablock, Nolicin
- Germany · Norfloxa, Norfloxacin 1 A Pharma
- Estonia · Nolicin
- Spain · Chibroxin, Norfloxacino Cinfa
- France · Chibroxine, Norfloxacine Biogaran
- Greece · Fluseminal, Norocin
- Croatia · Noflox, Nolicin
- Hungary · Nolicin, Nolicin-S
- Italy · Naflox, Norfloxacina Abc
- Lithuania · Nolicin
- Latvia · Nolicin, Norflox
- Malta · Norfloxacin Helcor
- Netherlands · Norfloxacine Cf, Norfloxacine Sandoz
- Poland · Chibroxin, Nolicin
- Portugal · Chibroxol, Norfloxacina Vitória
- Romania · Nolicin, Norfloxacin Helcor
- Slovenia · Nolicin
- Slovakia · Gyrablock, Nolicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ee54f15-0069-42ac-b12d-a4b59ebdcc5c GET /v1/drugs/4ee54f15-0069-42ac-b12d-a4b59ebdcc5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.8",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "g",
"strength": "400 mg",
"atc_label": "norfloksasiini",
"ma_number": "13767",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL10651",
"authorised_at": "1998-12-21"
}See everything about norfloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.